BIOAVAILABILITY AND BIOEQUIVALENCE

被引:15
作者
SKELLY, JP [1 ]
机构
[1] US FDA,ROCKVILLE,MD 20852
关键词
D O I
10.1177/009127007601601013
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:539 / 545
页数:7
相关论文
共 12 条
[1]   EVALUATION OF PHYSICAL AND PHARMACEUTICAL FACTORS INVOLVED IN DRUG RELEASE AND AVAILABILITY FROM CHLORAMPHENICOL CAPSULES [J].
AGUIAR, AJ ;
WHEELER, LM ;
FUSARI, S ;
ZELMER, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (11) :1844-&
[2]  
BERGAN T, 1973, ACTA PHARMACOL TOX, V33, P138
[3]  
GLAZKO AJ, 1968, CLIN PHARMACOL THER, V9, P472
[4]   LOS OF SENSITIVITY IN DISTINGUISHING REAL DIFFERENCES IN DISSOLUTION RATES DUE TO INCREASING INTENSITY OF AGITATION [J].
HAMLIN, WE ;
BALLARD, BE ;
WAGNER, JG ;
NELSON, E .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1962, 51 (05) :432-&
[5]   PHYSICOCHEMICAL BASIS OF THE BUFFERED ACETYLSALICYLIC ACID CONTROVERSY [J].
LEVY, G ;
HAYES, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1960, 262 (21) :1053-1058
[7]   SOLUTION RATE OF THEOPHYLLINE SALTS AND EFFECTS FROM ORAL ADMINISTRATION [J].
NELSON, E .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1957, 46 (10) :607-614
[8]   COMPARATIVE DISSOLUTION RATES OF WEAK ACIDS AND THEIR SODIUM SALTS [J].
NELSON, E .
JOURNAL OF THE AMERICAN PHARMACEUTICAL ASSOCIATION, 1958, 47 (04) :297-299
[9]  
SCHMIDT AM, 1975, FED REG 26142, V40
[10]   PHARMACOLOGICAL RESPONSE DATA FOR COMPARATIVE BIOAVAILABILITY STUDIES OF CHLORPROMAZINE ORAL DOSAGE FORMS IN HUMANS .1. PUPILLOMETRY [J].
SMOLEN, VF ;
MURDOCK, HR ;
STOLTMAN, WP ;
CLEVENGER, JW ;
COMBS, LW ;
WILLIAMS, EJ .
JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (11-1) :734-751